On February 3, with Pfizer (PFE) trading at $25.50, I opened my original LEAP position.
Why I Entered
I originally opened this trade based on:
- 📊 An earnings beat and the stock tanked the same day due to profit taking
- 📉 Consensus that the stock had been beaten down
- 📈 Analyst price targets ranging from $23–$35 per share
This wasn’t a lottery ticket.
It was a value-based thesis with defined risk.
My expectation was not explosive upside — but stabilization and recovery within a range.
📍 February 3 — Original Position
5 × Jun 17, 2027 $20 Calls
| Metric | Value |
|---|---|
| Underlying Price | $25.50 |
| Strike | $20 |
| Option Price | $7.47 |
| Delta | ~.90 |
| Synthetic Shares | 450 |
| Capital at Risk | $3,735 |
🧮 Exposure Math
.90 × 100 × 5 = 450 synthetic shares
Capital committed:
$7.47 × 100 × 5 = $3,735
At .90 delta, I was essentially long 450 shares.
If PFE went to $0, I could lose $3,735.
That was my maximum defined risk.
🧠 How the Thesis Evolved
Even with analyst targets between $23 and $35, I don’t expect a straight-line move.
My updated working assumptions:
- 📦 PFE likely channels
- 📉 Worst-case realistic scenario around $14
- 💰 Premium harvesting matters more than max delta
That’s what led to the roll.
🔁 The Roll to $25
I executed:
- Sold 5 $20 Calls @ $7.47
- Bought 5 $25 Calls @ $3.95
💰 Roll Credit
$7.47 – $3.95 = $3.52 per contract
$3.52 × 100 × 5 = $1,760 credit received
Immediate capital reduction.
📍 New Position
5 × Jun 17, 2027 $25 Calls
| Metric | Value |
|---|---|
| Strike | $25 |
| Option Cost | $3.95 |
| Gross Capital at Risk | $1,975 |
🧮 New Gross Risk
$3.95 × 100 × 5 = $1,975
That is the maximum loss on the LEAP itself.
💰 Covered Call Income
I also collected:
$150 from selling covered calls.
📊 True Net Capital at Risk
LEAP cost: $1,975
Minus covered call income: $150
= $1,825 net capital exposure
That is my real-world maximum downside today.
📉 Worst-Case Scenarios
If PFE Drops to $20
- $25 calls go OTM
- Delta shrinks
- I still have time (2027 expiration)
- I can continue selling calls
No forced assignment. No surprise purchase.
If PFE Drops to $14 (My Assumed Worst Case)
At expiration:
Calls expire worthless.
Loss = $1,825
If PFE Goes to $0
Same outcome.
Loss = $1,825
Defined risk remains defined.
⚖️ Before vs After
| February 3 Position | After Roll + Income | |
|---|---|---|
| Strike | $20 | $25 |
| Delta | .90 | Lower |
| Synthetic Shares | 450 | Reduced |
| Max Loss | $3,735 | $1,825 |
| Capital Freed | — | $1,760 |
📉 Risk Reduction
$3,735 – $1,825 = $1,910 less maximum exposure
That’s structural compression of risk.
🎯 Why This Still Fits the Original Thesis
Analysts see $23–$35.
That supports upside potential.
But I structured the trade assuming:
- It may stall near $23
- It may grind toward $30
- It may even dip before recovering
I don’t need 450 synthetic shares for that.
I need:
- Efficient exposure
- Reduced capital risk
- Flexibility to harvest premium
📌 Retail Trader Takeaway
If you remember nothing else from this post, remember this:
1️⃣ Delta Is Exposure
A .90 delta LEAP is basically stock.
5 contracts × .90 delta = 450 synthetic shares
Ask yourself:
Do I really want that much directional exposure for this stock?
2️⃣ Maximum Loss on a Long Call = Premium Paid (Minus Income)
Not the strike.
Not the intrinsic difference.
Not some scary theoretical number.
After the roll and covered call income:
True net max loss = $1,825
Even if PFE goes to $14.
Even if it goes to $0.
Defined risk means defined risk.
3️⃣ Rolling for Credit Can Compress Risk
Before roll:
Max loss = $3,735
After roll + income:
Max loss = $1,825
That’s $1,910 less exposure.
Rolling up didn’t increase risk.
It materially reduced it.
4️⃣ Structure Around Your Thesis
My thesis:
- 📦 Channeling stock
- 🐢 Slow movement
- 💰 Premium opportunities
If I believed PFE was about to rip higher, I would have kept the $20 strike and the .90 delta.
Position management should match probability — not hope.
🧠 Final Thought
Trading LEAPS isn’t about being right.
It’s about:
- Managing exposure
- Controlling maximum loss
- Improving return on capital
- Surviving the downside
This roll wasn’t exciting.
It was disciplined.
And disciplined trading compounds.


Leave a Reply